Authored By: Sarah
01 Feb 2022

Proton Pump Inhibitors (PPIs) Market | Leading Segments, Trends, Drivers and Challenges

Market Recovery and Growth Projections 2021-2025

Global proton pump inhibitors (ppis) market is likely to post an incremental growth of $ 3.45 bn, accelerating at a CAGR of  4.17% during the forecast period. This research provides a detailed analysis of the market segments and geographic landscape. It also offers insights into the various growth factors and challenges that are likely to have a negative impact on market growth. This thorough research will equip clients with the insights necessary to plan and strategize a post-pandemic recovery plan.


Request for Our Free Sample Report for detailed Insights


Proton Pump Inhibitors (PPIs) Market Size to Grow by $ 3.45 bn through 2021-2025 | Leading Segments and Market Trends

Proton Pump Inhibitors (PPIs) Market: Market Segments and Growth Forecasts

This research report will provide insights into the current market share of each segment along with growth projections for the next five years.

  • Market is segmented by Product (OTC PPIs and prescription PPIs) and Geography (North America, Europe, Asia, and ROW).
  • 35% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Proton Pump Inhibitors (PPIs) Market size.

Proton Pump Inhibitors (PPIs) Market Size to Grow by $ 3.45 bn through 2021-2025 | Leading Segments and Market Trends

Proton Pump Inhibitors (PPIs) Market: Trends, Drivers, Challenges

The report also offers a detailed impact analysis of various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will equip clients to design a growth strategy for their business and area of operations.

  • Reformulation of drugs will be a significant factor in driving the growth of the Proton Pump Inhibitors (PPIs) Market.
  • Growth in prescription rate will be instrumental in driving the market growth during the forecast period.
  • Increasing lawsuits against PPIs is a hurdle that needs to be crossed on the path to success.

Proton Pump Inhibitors (PPIs) Market: Vendor Analysis

  • The market is fragmented.
  • AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Johnson and Johnson Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. are some of the major market participants.
  • The unprecedented outbreak of COVID-19 in 2020 has had a significant impact on market segments had a ripple effect on various stakeholders. Our vendor analysis and insights will provide you with all the information required to make the most of the opportunities and plan business recovery and growth post the pandemic.

Key Areas Covered in our Report:

  • Proton Pump Inhibitors (PPIs) Market Split by Product
    • OTC PPIs
    • prescription PPIs
  • Proton Pump Inhibitors (PPIs) Market Split by Geography
    • North America
    • Europe
    • Asia
    • ROW

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC - Market size and forecast 2020-2025
  • MEA - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • South America - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cadila Pharmaceuticals Ltd.
  • Dr. Reddys Laboratories Ltd.
  • Eisai Co. Ltd.
  • Johnson and Johnson Inc.
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market will accelerate at a CAGR of 4.17%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 3.45 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    Reformulation of drugs will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    35% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Johnson and Johnson Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.

     
  7. What are the market segments covered in this report?
    The market is segmented by Product (OTC PPIs and prescription PPIs) and Geography (North America, Europe, Asia, and ROW)
Read News Read Less
Interested in this report?
Get your sample now!
Technavio
Document